Arsanis
Latest round
- Series D
Last raised
- Apr 2017
Total raised
- $84M
Investors
- 9
About Arsanis
Founded in 2010 and based in Massachusetts, United States, Arsanis, Inc. is a biopharmaceutical company that develops human monoclonal antibody therapeutics for the treatment of critical infectious diseases. In March 2019, X4 Pharmaceuticals merged with Arsanis, Inc. (Nasdaq: ASNS). In connection with the merger, Arsanis changed its name to X4 Pharmaceuticals, Inc. The combined organization commenced trading on March 14, 2019 on the Nasdaq Capital Market under the symbol XFOR.
Who invested in Arsanis
9 investors across 4 rounds
See all investors in Arsanis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arsanis
Who invested in Arsanis?
Arsanis has 9 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arsanis raised?
Arsanis has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Arsanis last raise money?
Arsanis's most recent round on record is a Series D, in Apr 2017.
What does Arsanis do?
Founded in 2010 and based in Massachusetts, United States, Arsanis, Inc.
Where is Arsanis headquartered?
Arsanis is headquartered in Waltham, US.
Which VCs invest in companies like Arsanis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Arsanis's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series D
Raising like Arsanis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.